Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals, Inc.verified

AVIR

Price:

$3.25

Market Cap:

$274.51M

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The company also develops AT-752, an oral purine nucleoside prodrug product candidate, which has completed Phase Ia clinical trial for the treatment of dengue; AT-777, an NS5A inhibitor; AT-787, a co-formulated, oral, pan-genotypic fixed dose combination of AT-527 and AT-777 for the treatment of hepatitis C virous (HCV); and AT-281, a pharmaceutically acc...[Read more]

Industry

Biotechnology

IPO Date

2020-10-30

Stock Exchange

NASDAQ

Ticker

AVIR

The Enterprise Value as of December 2024 (TTM) for Atea Pharmaceuticals, Inc. (AVIR) is 177.88M

According to Atea Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 177.88M. This represents a change of 37.15% compared to the average of 129.69M of the last 4 quarters.

Atea Pharmaceuticals, Inc. (AVIR) Historical Enterprise Value (quarterly & annually)

How has AVIR Enterprise Value performed in the past?

The mean historical Enterprise Value of Atea Pharmaceuticals, Inc. over the last ten years is 1.05B. The current 177.88M Enterprise Value has changed 1.59% with respect to the historical average. Over the past ten years (40 quarters), AVIR's Enterprise Value was at its highest in in the March 2021 quarter at 4.27B. The Enterprise Value was at its lowest in in the December 2022 quarter at -242971456.41.

Quarterly (TTM)
Annual

Average

1.05B

Median

756.64M

Minimum

-243174698.15

Maximum

2.59B

Atea Pharmaceuticals, Inc. (AVIR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Atea Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 923.17%

Maximum Annual Enterprise Value = 2.59B

Minimum Annual Increase = -146.43%

Minimum Annual Enterprise Value = -243174698.15

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023112.92M-146.43%
2022-243174698.15923.17%
2021-23766869.22-100.92%
20202.59B4.39%
20192.48B77.45%

Atea Pharmaceuticals, Inc. (AVIR) Average Enterprise Value

How has AVIR Enterprise Value performed in the past?

The current Enterprise Value of Atea Pharmaceuticals, Inc. (AVIR) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-51341276.62

5-year avg

985.00M

10-year avg

1.05B

Atea Pharmaceuticals, Inc. (AVIR) Enterprise Value vs. Peers

How is AVIR’s Enterprise Value compared to its peers?

Atea Pharmaceuticals, Inc.’s Enterprise Value is greater than Immix Biopharma, Inc. (41.37M), greater than CNS Pharmaceuticals, Inc. (-675887.00), greater than Hepion Pharmaceuticals, Inc. (4.21M), greater than Freeline Therapeutics Holdings plc (2.82M), greater than AVROBIO, Inc. (-85302404.00), greater than Enveric Biosciences, Inc. (40.99K), greater than CohBar, Inc. (-4157504.00), greater than Elevation Oncology, Inc. (16.16M), greater than Ocean Biomedical, Inc. (31.52M), greater than eFFECTOR Therapeutics, Inc. (4.74M),

Build a custom stock screener for Atea Pharmaceuticals, Inc. (AVIR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atea Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atea Pharmaceuticals, Inc. (AVIR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atea Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Atea Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Atea Pharmaceuticals, Inc. (AVIR)?

What is the 3-year average Enterprise Value for Atea Pharmaceuticals, Inc. (AVIR)?

What is the 5-year average Enterprise Value for Atea Pharmaceuticals, Inc. (AVIR)?

How does the current Enterprise Value for Atea Pharmaceuticals, Inc. (AVIR) compare to its historical average?